These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8950856

  • 1. [Expression of S.sonnei form I antigen gene and V.cholerae toxin B subunit gene in S.flexneri 2a strain and investigation of their immunoprotective response in mice].
    Qian F, Rui X, Su G, Huang C.
    Yi Chuan Xue Bao; 1996; 23(4):322-8. PubMed ID: 8950856
    [Abstract] [Full Text] [Related]

  • 2. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X, Xu Y, Wan H, Su G, Huang C.
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [Abstract] [Full Text] [Related]

  • 3. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH, Ashkenazi S, Harlev E, Miron D, Ramon R, Farzam N, Lerner-Geva L, Levi Y, Chu C, Shiloach J, Robbins JB, Schneerson R, Israel Shigella Study Group.
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [Abstract] [Full Text] [Related]

  • 4. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ.
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [Abstract] [Full Text] [Related]

  • 5. Construction of a Salmonella typhimurium vaccine strain expressing Vibrio cholera CT-B and LPS-O antigen.
    Chen D, Ma Q.
    Chin J Biotechnol; 1997 Apr; 13(1):43-50. PubMed ID: 9376506
    [Abstract] [Full Text] [Related]

  • 6. [Immunologic properties of coli surface antigen 6(CS6) of enterotoxigenic Escherichia coli and cholera toxin subunit B expressed in Shigella flexneri 2a strain T32].
    Ying TY, Han ZZ, Feng EL, Wang HL, Zhang ZS, Su GF, Huang CF.
    Sheng Wu Gong Cheng Xue Bao; 2001 Jan; 17(1):29-33. PubMed ID: 11330183
    [Abstract] [Full Text] [Related]

  • 7. Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.
    Said Hassane F, Phalipon A, Tanguy M, Guerreiro C, Bélot F, Frisch B, Mulard LA, Schuber F.
    Vaccine; 2009 Aug 27; 27(39):5419-26. PubMed ID: 19559116
    [Abstract] [Full Text] [Related]

  • 8. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S, Passwell JH, Harlev E, Miron D, Dagan R, Farzan N, Ramon R, Majadly F, Bryla DA, Karpas AB, Robbins JB, Schneerson R.
    J Infect Dis; 1999 Jun 27; 179(6):1565-8. PubMed ID: 10228084
    [Abstract] [Full Text] [Related]

  • 9. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN, Osorio M, Takeda K, Stibitz S, Kopecko DJ.
    Clin Vaccine Immunol; 2017 Dec 27; 24(12):. PubMed ID: 29046309
    [Abstract] [Full Text] [Related]

  • 10. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV, Turbyfill KR.
    Vaccine; 2006 Mar 20; 24(13):2290-301. PubMed ID: 16364513
    [Abstract] [Full Text] [Related]

  • 11. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV, Roberts F, Verma NK.
    FEMS Immunol Med Microbiol; 2006 Apr 20; 46(3):444-51. PubMed ID: 16553820
    [Abstract] [Full Text] [Related]

  • 12. Regulated Delayed Shigella flexneri 2a O-antigen Synthesis in Live Recombinant Salmonella enterica Serovar Typhimurium Induces Comparable Levels of Protective Immune Responses with Constitutive Antigen Synthesis System.
    Su H, Liu Q, Wang S, Curtiss R, Kong Q.
    Theranostics; 2019 Apr 20; 9(12):3565-3579. PubMed ID: 31281498
    [Abstract] [Full Text] [Related]

  • 13. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X, Ma Q.
    Chin J Biotechnol; 1994 Apr 20; 10(4):225-32. PubMed ID: 7780018
    [Abstract] [Full Text] [Related]

  • 14. Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates.
    Klee SR, Tzschaschel BD, Singh M, Fält I, Lindberg AA, Timmis KN, Guzmán CA.
    Microb Pathog; 1997 Jun 20; 22(6):363-76. PubMed ID: 9188091
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.